Therapeutic Goods Legislation Amendment (Annual Charges) Act 2008
No. 96, 2008
An Act to amend the law relating to therapeutic goods, and for related purposes
Contents
1 Short title
2 Commencement
3 Schedule(s)
Schedule 1—Amendments
Therapeutic Goods Act 1989
Therapeutic Goods (Charges) Act 1989
Therapeutic Goods Legislation Amendment (Annual Charges) Act 2008
No. 96, 2008
An Act to amend the law relating to therapeutic goods, and for related purposes
[Assented to 3 October 2008]
The Parliament of Australia enacts:
1 Short title
This Act may be cited as the Therapeutic Goods Legislation Amendment (Annual Charges) Act 2008.
2 Commencement
(1) Each provision of this Act specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provision(s) | Commencement | Date/Details |
1. Sections 1 to 3 and anything in this Act not elsewhere covered by this table | The day on which this Act receives the Royal Assent. | 3 October 2008 |
2. Schedule 1 | A single day to be fixed by Proclamation. However, if any of the provision(s) do not commence within the period of 6 months beginning on the day on which this Act receives the Royal Assent, they commence on the first day after the end of that period. | 1 January 2009 (see F2008L04263) |
Note: This table relates only to the provisions of this Act as originally passed by both Houses of the Parliament and assented to. It will not be expanded to deal with provisions inserted in this Act after assent.
(2) Column 3 of the table contains additional information that is not part of this Act. Information in this column may be added to or edited in any published version of this Act.
3 Schedule(s)
Each Act that is specified in a Schedule to this Act is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this Act has effect according to its terms.
Schedule 1—Amendments
Therapeutic Goods Act 1989
1 Section 44
Repeal the section, substitute:
44 Time for payment of charges
Annual registration charge, annual listing charge or annual charge for inclusion in the Register
(1) An annual registration charge, annual listing charge or annual charge for inclusion in the Register for a financial year becomes payable:
(a) if the registration, listing or inclusion in the Register of the therapeutic goods concerned commenced in that financial year—on the day worked out under the regulations; and
(b) in any other case:
(i) on 1 October in that year; or
(ii) if the regulations specify another day for the purposes of this subparagraph—on that other day in that year.
This subsection is subject to subsection (3).
Annual licensing charge
(2) An annual licensing charge for a financial year becomes payable:
(a) if the licence commenced in that financial year—on the day of that commencement; and
(b) in any other case:
(i) on 1 October in that year; or
(ii) if the regulations specify another day for the purposes of this subparagraph—on that other day in that year.
This subsection is subject to subsection (3).
Charge may become payable on a later day
(3) The Secretary may, by notice in writing given to a person, specify a later day on which a charge referred to in subsection (1) or (2) becomes payable by the person for a financial year. The notice has effect accordingly.
Interpretation
(4) This section is subject to section 44A.
2 After section 44
Insert:
44A Exemptions from liability to pay charges
(1) The regulations may make provision for and in relation to:
(a) exempting a person from liability to pay annual registration charge, annual listing charge or annual charge for inclusion in the Register for a financial year (the current year) if the person’s turnover of the therapeutic goods concerned for the financial year specified in the regulations is of low value; and
(b) the making of an application for an exemption and requiring payment of that charge for the current year if the application is refused; and
(c) cancelling an exemption and requiring payment of that charge for the current year.
Fees
(2) The regulations may require applications for exemptions to be accompanied by a specified fee. A fee must not be such as to amount to taxation.
Statements prepared by approved persons
(3) The regulations may require a person who is applying for an exemption, or who has been granted an exemption, to provide a statement:
(a) that is prepared by an approved person; and
(b) that specifies whether the person’s turnover of the therapeutic goods concerned for the financial year concerned is of low value.
Additional information
(4) The regulations may provide for the obtaining of additional information or documents from applicants for exemptions or persons granted exemptions.
Merits review
(5) The regulations may provide for review by the Administrative Appeals Tribunal of decisions of the Secretary to refuse applications for exemptions or to cancel exemptions.
No limit on subsection (1)
(6) Subsections (2) to (5) do not limit subsection (1).
Low value turnover
(7) For the purposes of this section, the regulations may specify when a person’s turnover of therapeutic goods for a financial year is of low value. The regulations may specify different rules for different therapeutic goods.
Interpretation
(8) This section does not limit paragraph 63(3)(b) (about the refund, reduction or waiving of fees or charges).
Definitions
(9) In this section:
approved person means a person included in a class of persons specified in regulations made for the purposes of this definition.
turnover has the meaning prescribed by the regulations.
3 Application
(1) The amendment made by item 1 applies in relation to the financial year beginning on 1 July 2009 and all later financial years (regardless of whether the registration, listing or inclusion in the Register of the therapeutic goods, or whether the licence, commenced before, on or after 1 July 2009).
(2) The amendment made by item 2 applies for the purposes of working out whether a person is exempt from liability to pay annual registration charge, annual listing charge or annual charge for inclusion in the Register for the financial year beginning on 1 July 2009 and all later financial years.
Therapeutic Goods (Charges) Act 1989
4 Subsections 4(3) to (6)
Repeal the subsections, substitute:
Corresponding State laws
(3) If, because of the operation of section 6AAE of the Therapeutic Goods Act, goods are included in the part of the Register for goods known as registered goods, this section has effect as if the goods had been registered under Part 3‑2 of that Act.
(4) If, because of the operation of section 6AAE of the Therapeutic Goods Act, goods are included in the part of the Register for goods known as listed goods, this section has effect as if the goods had been listed under Part 3‑2 of that Act.
(5) If, because of the operation of section 6AAE of the Therapeutic Goods Act, goods are included in the part of the Register for medical devices included under Chapter 4, this section has effect as if the goods had been included in the Register under Chapter 4 of that Act.
(6) If:
(a) because of the operation of section 6AAA, 6AAB or 6AAC of the Therapeutic Goods Act, the Secretary issues a licence; and
(b) the licence is issued for the purposes of provisions of a corresponding State law that correspond to Part 3‑3 of the Therapeutic Goods Act;
this section has effect as if the licence had been issued under Part 3‑3 of that Act.
Definitions
(7) In this section:
amount includes a nil amount.
Therapeutic Goods Act means the Therapeutic Goods Act 1989.
5 Subsection 5(3)
Repeal the subsection.
6 Saving
Despite the repeal of subsection 5(3) of the Therapeutic Goods (Charges) Act 1989 made by this Act, that subsection continues to apply after the commencement of this item in relation to working out whether the annual charges mentioned in that subsection are payable by persons for the financial year beginning on 1 July 2008 and all earlier financial years.
[Minister’s second reading speech made in—
House of Representatives on 18 June 2008
Senate on 27 August 2008]
(134/08)